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Abstract Nutrients in seafood are known to be
beneficial for brain development. Effects of maternal
exposure to 2,2′,4,4′ tetrabromo diphenylether
(BDE47) was investigated, alongside the potential
ameliorating impact of seafood nutrients, through
assessment of neurobehaviour and gene expression
in brain and liver. Developing mice were exposed
during gestation and lactation via dams dosed through
casein- or salmon-based feed, spiked with BDE47.
Two concentrations were used: a low level (6 μg/kg
feed) representing an environmentally realistic con-
centration and a high level (1,900 μg/kg feed)
representing a BDE47 intake much higher than
expected from frequents consumption of contaminat-
ed seafood. Experimental groups were similar with
respect to reproductive success, growth and physical
development. Minor, transient changes in neurobeha-
vioural metrics were observed in groups given the
highest dose of BDE47. No significant differences in
behaviour or development were seen on postnatal
day 18 among maternally exposed offspring. Cerebral
gene expression investigated by microarray analyses
and validated by RT-qPCR showed low fold changes
for all genes, despite dose-dependent accumulation of
BDE47 in brain tissue. The gene for glutamate
ammonia ligase was upregulated compared to control
in the casein-based high BDE47diet, suggesting
potential impacts on downstream synaptic transmis-
sion. The study supported a previously observed
regulation of Igfbp2 in brain with BDE47 exposure.
Genes for hepatic metabolic enzymes were not
influenced by BDE47. Potential neurotoxic effects
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Introduction
The presence of polybrominated diphenylethers
(PBDEs) has been documented in exponentially increas-
i n gl e v e l si na n i m a l sa n dh u m a n sf r o mt h e1 9 7 0 su n t i l
thepresent(Meironyteetal.1999; Noren and Meironyte
2000). Infants are exposed to relatively high levels of
PBDEs and other persistent, fat-soluble organohalogens
during gestation and lactation (Guvenius et al. 2003;
Furst 2006). Several studies have documented neuro-
toxic effects of PBDEs in vitro (Kodavanti 2005;
Reistad et al. 2006;H ee ta l .2008), and long-term
adverse effects of PBDEs have been shown at doses too
low to produce overt toxicity or altered physical
development in vivo (Viberg et al. 2006; Gee and
Moser 2008). In particular, altered spontaneous behav-
iour has been seen in mice after exposure to a single
low oral dose of PBDEs [≤1 mg/kg bodyweight (BW)]
during the vulnerable brain growth spurt (BGS)
(Eriksson et al. 2002; Viberg et al. 2003b, 2006;G e e
and Moser 2008). Mechanistic studies have shown
changes in the density of cholinergic receptors in the
hippocampus and reduced dopamine levels in vivo after
PBDE exposure during the BGS (Viberg et al. 2003a;
Gee et al. 2008), and intracellular signalling in neurons
also seems to be disrupted in vitro (Kodavanti and
Derr-Yellin 2002; Kodavanti 2005). These cellular and
biochemical changes may underlie the behavioural
effects observed. This indicates that changes may be
present in both the structure and functionality of the
brain after acute exposure to PBDEs.
Seafood is a rich source of many beneficial
nutrients as well as a major source of dietary
contaminants for seafood consumers (Bonham et al.
2009). International public guidelines advise pregnant
women to increase their intake of seafood and oily
fish due to the beneficial nutrients (WHO/FAO, 2002;
EFSA, 2005), as there is ample evidence of detri-
mental effects linked to maternal nutritional deficits
during gestation (review by Bourre 2006). Moreover,
foods and nutrients have been shown to protect
against a range of toxic effects. Examples include
sequestration of methyl mercury by selenium (Peraza
et al. 1998), reduction of the accumulation of penta-
and hexachlorobenzene with fish-oil consumption
(Umegaki et al. 1995; Umegaki and Ikegami 1998)
and reduction of the acute toxicity of dioxins by
antioxidants such as vitamins A and E (Alsharif and
Hassoun 2004). Epigenetic modifications in offspring
by maternal nutrient supplementation have also been
shown (Dolinoy et al. 2007). The potential ameliorat-
ing effect of dietary nutrients on the toxic response to
environmental contaminants needs to be further
evaluated. Few experimental studies examine the
detrimental effects of exposure to PBDE concentra-
tions and routes of exposure relevant to humans,
which would be of interest for dietary advice to
consumers.
Structural and functional changes in the brain
have been seen after perinatal PBDE exposure
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would be expected that such changes were preceded
by regulatory changes in, i.e. cerebral gene expres-
sion. Toxicogenomics offers the advantage of screen-
ing the entire transcriptome and may provide a
mechanistic link between early gene expression
changes and later functional and structural changes.
A toxicogenomic approach may thus accelerate our
understanding of the mechanism underlying PBDE
toxicity. Despite the demonstrable effects of PBDEs on
the central nervous system, there is, to our knowledge,
only one previous in vivo study concerning toxicoge-
nomic effects of PBDEs (Suvorov et al. 2011), which
reported regulation of a limited number of thyroid
responsive genes in rat brain and liver after exposure to
2,2′,4,4′-tetrabromo diphenylether (BDE47). Due to the
tractability for genomics, research mice were consid-
ered to be a suitable model to use for this study.
The objective of the present study was to evaluate
the possible adverse effects of exposure to BDE47
during development, including both the gestational
and lactational transfer from mouse dam to offspring
via the placental circulation and via breast milk. The
exposure period and route of exposure are highly
relevant to humans. Overt clinical toxicity was not
expected with this approach; hence, the use of
sensitive early markers was imperative.
Furthermore, the study aimed to examine whether
any ameliorating effect of nutrients could be detected
with a maternal high-fish diet. Brain and tissue
accumulation of BDE47, global cerebral gene expres-
sion, physical and neurobehavioural development and
spontaneous behaviour were evaluated in maternally
exposed murine offspring. The liver enzymes responsi-
ble for the major part of mammalian xenobiotic
metabolism are often induced by the presence of the
compoundstheymetabolise,includingBDE47(Sanders
et al. 2006), and are widely used as markers of toxic
responses. The transcriptional regulation of the hepatic
enzymes, Cyp1a1,C yp2b10,a n dC yp3a11 was there-
fore assessed as a measure of the general toxic
response to the current exposure to BDE47.
Materials and methods
The experiment and the animal facilities were
approved by the National Animal Research Authority
(NARA/FDU, Norway).
Experimental feeds
Animals were exposed to BDE47 via the food to
mimic human exposure. The experimental diets were
produced in-house, according to the AIN-93G rodent
diet to meet 1995 NRC rat/mouse reproduction,
gestation and lactation values (DYETs Inc. formula-
tion 110800). In order to investigate the effects of
nutritional differences, two sets of diets were pro-
duced, one with and one without fish included.
Briefly, the casein-based diet used casein sodium salt
(Sigma Aldrich Inc.) as the sole source of protein and
soy-bean oil as the source of lipid. The experimental,
fish-based diets had 15% (per weight) inclusion of
freeze-dried Atlantic salmon (Salmo salar), supple-
mented with casein and soy oil to meet the desired
protein and fat contents, respectively. All diets
contained 17% protein and 10% fat (per weight).
The salmon was experimentally raised for the EU-
project AQUAMAX (EU-Contract no. 016249-2)
using maximum plant protein and vegetable oil
substitution in the fish feed (Torstensen et al. 2008),
which gave very low levels of contaminants in the
fish (Berntssen et al. 2010).
To investigate the effects of BDE47, the diets were
spiked with high purity BDE47 (Cambridge Isotope
Laboratories, MA, USA, and Chiron AS, Norway). The
crystalline BD47 was dissolved and diluted in 100%
dimethylsulfoxide (DMSO) to appropriate concentra-
tions andaddedtothe soy-beanoilofeachexperimental
diet. DMSO was added to all feeds at a final
concentration of 0.4 ml/kg. Six diets were produced:
casein control, casein low level, casein high level, fish
control, fish low level and fish high level. The “low
level” aimed at a BDE47 concentration two to three
times higher than the concentration typically found in
Norwegian farmed Atlantic salmon (Bethune et al.
2006). A previous study found that the background
dietary intake of 7PBDEs in Norwegians was 1.1 ng kg
BW
−1 day
−1 (Knutsen et al. 2008). The low level
exposure (∼6 μg BDE47/kg feed) would exceed the
human background intake ∼2,000 times when the 30-g
mouse consumed 10 g feed/day during lactation, equal
to 2 μg BDE47/kg BW. The “high level” feed
concentration (∼1,900 μg BDE47/kg feed) represented
consumption of fish with high concentrations of
BDE47 and was estimated to give a peak intake of
∼650 μgk gB W
−1 day
−1 (∼1.4 μmol kg BW
−1 day
−1)
for a 30-g mouse consuming 10 g feed/day during
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PBDE intake by hobby fishermen frequently consum-
ing fish from the heavily polluted Lake Mjøsa
approximately 13,000 times (Thomsen et al. 2008).
Food safety authorities have not agreed on tolerable
weekly intake estimates for the non-coplanar, non-
dioxinlike compounds such as BDE47. The estimates
of pup exposure (μgk gB W
−1 day
−1) were based on an
80% oral absorption efficiency of BDE47 (Staskal et
al. 2005), a 20% transfer rate in milk (Darnerud and
Risberg 2006) and a mean litter size of six pups/litter.
the “high level” used in the present study aimed at a
daily or accumulated dose to the growing pups in the
range of what has previously given effects on
spontaneous behaviour after a single oral dose of
1.4 μmol/kg BW to pups on PND10 (Eriksson et al.
2001). The pup exposure would vary based on
maternal intake and lactational transfer, pup body-
weight and the number of pups per litter. The
individual pup exposure was of less importance, as
the litter was considered a statistical unit in all later
analyses. The repeated exposure of pups was assumed
to result in higher accumulated BDE47 exposure than
the single exposure previously used (Eriksson et al.
2001), and thus, the exposure was expected to give
measurable effects.
Analyses of feeds
Feeds were analysed for congeners (IUPAC nos.
BDE28, BDE47, BDE99, BDE100, BDE153,
BDE154 and BDE183) and hexabromo cyclodode-
cane by gas chromatography/mass spectrometry (GC/
MS) according to previously described methods
(Bethune et al. 2005). This method was adapted to
quantify high concentrations of PBDE in feeds and
tissues. The adaptations consisted of adding 40 times
more internal standard to high level feeds than control
feeds before the extraction to bring the concentration
of internal standard into the same order of magnitude
as the BDE47 in the sample. The extracts from high
level samples were then diluted in 20 ml nonane (99%
pure, Sigma-Aldrich) before injection into the GC to
bring the concentrations down to the linear range of
the standard curve. The procedure diluted congeners
other than the added BDE47 below the limit of
quantification (LOQ). To ensure similarity among
feeds, nutrients were also quantified in each feed.
Protein content was analysed via the combustion
method determining total nitrogen, using a Leco FP-
528 and Leco Software (Leco Corp., MI, USA),
according to the “Association of Official Analytical
Chemists Official Method 992.15 for Crude Protein in
Meat and Meat Products Including Pet Foods”. Crude
protein was calculated assuming that protein contains
16% nitrogen. Total fat content was determined
gravimetrically using ethylacetate extraction
(NS9402 1994). Fatty acid composition was analysed
(Lie and Lambertsen 1991; Torstensen et al. 2008),
and individual fatty acids were identified by known
purified standards. Vitamin A (all-trans-retinol) was
analysed by high performance liquid chromatography
(HPLC) with a UV-detector (325 nm) according to
Moren et al. (2002). Vitamin D3 was analysed
according to Horvli et al. (1994). Vitamin E (α-
tocopherol) was analysed by normal phase HPLC
with fluorescence detection (excitation of 289 nm and
emission of 331 nm) according to Hamre et al.
(2010). Heavy metals (arsenic, mercury, cadmium,
lead and selenium) were analysed by inductively
coupled plasma/MS (Julshamn et al. 2007).
Animal exposure
Sixty BALB/c mice were supplied by Taconic Inc,
Denmark. The females (n=48) were previously
proven breeders (one to two litters). Females were
randomly divided into experimental groups and
housed three to four females per cage in large rat
cages (Eurostandard Type IV) with environmental
enrichment, under laboratory conditions of 23±1°C,
55±5% relative humidity and 12:12 h light/dark
cycle. Lights were on 0800–2000 hours. Groups were
randomly and evenly distributed within racks to
compensate for environmental variation. Control
feeds were given during acclimation and oestrus
stimulus (total of 9 days). As pups are exposed to
BDE47 via the placental circulation and through
breast milk during lactation (Darnerud and Risberg
2006), spiked feeds were given from the first day of
mating [gestation day (GD) 0] until the end of trial on
postnatal day (PND)18 (Fig. 1). One male was mated
with three to four females during 1 week ( about two
oestrus cycles). Females were housed individually
from GD16 through lactation to monitor individual
litter development during lactation, and the feed
intake during this period was also monitored individ-
ually. Spillage of the powdered feed was limited by
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monitored by sieving the bedding to remove the
powdered feed during and after the trial. Cages were
checked twice daily for litters from GD18, and the
day of birth was denoted as PND0. Feed and water
was given ad libitum, and the feed intake monitored
for each mouse by weighing any uneaten food daily.
The feed intake by individual dams was calculated in
order to compare both nutritional status and group
exposure to BDE47. During mating and the first two
weeks of gestation, the food intake was averaged per
cage. During individual housing from GD16, the
individual feed intake was monitored. Dam feed
intake during gestation represented feed consumption
during the 21 days prior to PND0. Dam exposure
during lactation (μgk gB W
−1 day
−1) was calculated
based on the monitored daily feed intake from PND0
to PND18 and the bodyweight on the last weighing
during gestation (GD16).
The nests were left undisturbed until PND5 to
avoid maternal aggression, which has been observed
after disturbance of BALB/c as late as PND3 (Folven,
pers. comm.). The term “litter size” therefore reflects
the verified number of live pups on PND5, counted
before sampling commenced. Large litters were
reduced to five pups on PND5 both to obtain tissue
for analyses and to reduce variation in the amount of
feed consumed by the dams. Reducing the largest
litters would also ensure adequate nutrition of all
pups.
Physical development and neurobehavioural testing
Two random pups per litter were tested from 0800 to
1400 hours on PND5, PND8, PND11, PND15 and
PND18 for physical and behavioural development by
a single experimenter who was unaware of the group
exposure. The behavioural tests were based on the so
called Fox-battery (Fox 1965) with adjustments made
according to Bignami (1996) and Folven et al. (2009).
Tests were performed as described in Folven et al.
(2009). Pups were weighed and observed for markers
of physical development every day of testing. The
behavioural test battery included righting reflex, fore-
and hind limb grasp and hang-climb ability (all tested
on PND5–PND11), auditory startle reflex (PND5–
PND15), visual placing, cliff drop aversion and grip
strength (all tested on PND15 and PND18) and hind
limb splay (PND18 only). Pup and adult forelimb grip
strength was tested on PND18 by a grip strength
meter (San Diego Instruments Inc., San Diego, CA,
USA). On PND18, pups and adults were tested for
spontaneous behaviour and emotional reactivity in an
elevated plus maze (San Diego Instruments Inc., San
Diego, CA, USA), assessing distance travelled, time
spent resting, number of zone crossings and perma-
nence time in each zone. A modification in the startle
reflex test consisted in using a metal click-box was to
produce a sudden, sharp noise for the auditory startle
reflex. For the hang-climb test, graded levels of
climbing were scored in the following manner: 0=
no hang, 1=1–14 s, 2=15–29 s, 3=30–44 s, 4=45–
59 s, 5=>60 s, 6=successfully moving and replacing
two limbs, 7=successfully replacing three limbs and
8=successfully replacing all four limbs.
Statistical analyses of animal development
and behaviour
The statistical methods used kept the litter as the
experimental and statistical unit as recommended in
testing of multiparous species (Piegorsch and Haseman
1991; Holson and Pearce 1992).
All comparisons of reflex scores were initially
based on the mean litter score (Supplementary
Table A) using either one-way ANOVA or the non-
Arrival
Birth:G D21/PND0
PND5
~1 week 1 week 2 weeks
PND1 1
PND 8
Behavioural testing
Experimental feed with BDE47
~3 weeks
Gestation Acclimation
GD0
Mating
PD 18
N
15
P D
N
Control feed
PND 18 tissue sampling Fig. 1 Experimental outline.
Reproducing BALB/c mice
were exposed to BDE47
during mating, gestation and
lactation. Mice offspring
were treated and handled
from postnatal day (PND) 5
as indicated. GD Gestation
day
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testing with Mann–Whitney U test, according to
previously published methods (Folven et al. 2009).
Homogeneity of variance was assessed by Levene’s
test, and normal distribution was assessed by Shapiro–
Wilk’s test of normality. Normally distributed data with
homogeneous variance were compared using the para-
metricone-wayANOVA(theBrown–Forsythetest)and
Student’s t test. Data that were not normally distribut-
ed, or had non-homogeneous variance, were tested by
Kruskal–Wallis test for independent samples and
Mann–Whitney U pair wise comparison (with two-
tailed exact test) (SPSS v 15.0 for windows; SPSS Inc,
Chicago, IL, USA). Data from the elevated plus maze
were analysed as according to Folven et al. (2009).
The reflexes ”righting” and “hind limb grasp”
appeared to be influenced by litter size. The mean
litter score approach does not allow correction for the
influence of litter size; thus, a generalised linear
model (GLM) with binomial distribution was
employed using the statistical software “R” v.2.9.0
(R Development Core Team 2009) in an attempt to
delineate the effects of the litter size. The GLM model
assessed how the response characteristics were influ-
enced by the independent predictors “diet” (fish or
casein), “concentration” (control, low, high) and “litter
size” (1–11 pups), and their interactions. In the
GLM model, each dam was considered an indepen-
dent observation, and each pup tested was a trial
under that observation. The response variable was
the number of successful scores in relation to the
number of tested pups per litter. Ideally, the GLM
method requires behavioural testing of more than
two pups per litter, and the method was therefore
only applied to the behavioural tests where signif-
icant difference was found when using the mean
litter score.
A generalised least square regression (GLS) was
used to model feed intake by dams in relation to
BDE47 level, diet (fish or casein) and litter size. A
linear mixed effect model (LME) (Pinheiro and Bates
2000) was used to investigate the differences in pup
body weight and hepatosomatic index (HSI), with the
dam as the random variable. GLM, LME and GLS
adjust for the uneven variance (heteroscedascity) of
the residuals. The statistical models were selected
from backward elimination of full three-way inter-
actions, deleting non-significant terms. The methods
were based on previous publications, presented in
Zuur et al. (2009). Post hoc test was Tukey’s honestly
significant difference, where applicable. Significance
levels were set at alpha=0.05 for all methods.
Tissue sampling
Animals were anaesthetised using a ventilated cham-
ber Univentor 400 (Univentor Ltd., Malta) with 4%
gaseous Isofluran and ∼400 ml/min airflow, and then
euthanised by cervical dislocation. The brain and liver
were quickly removed with RNAse free equipment
and weighed. HSI is defined as (liver weight/body
weight)×100.
Tissues for RNA extraction were frozen in liquid
nitrogen and stored at −80°C until processing. Tissue
for analysis of PBDE concentrations were frozen at
−20°C and analysed by GC/MS (Bethune et al. 2005)
with modifications as described for the analysis of
feeds. Tissue samples for PBDE analysis were
thawed, weighed and manually homogenised before
extraction.
Microarray analysis
Total RNA was extracted from the right hemisphere of
the brain from female pups (PND18), using Trizol
reagent (Invitrogen, Life Technologies, Carlsbad, CA,
USA) combined with the Qiagen RNeasy-Mini kit
(Qiagen, Mississauga, ON, Canada). Extracted RNA
was stored at −80°C until further processing. RNA
purity was assessed using Nanodrop ND-100 UV-Vis
Spectrophotometer (Nanodrop Technologies, Wilming-
ton, DE, USA), and RNA quality and integrity were
evaluated using the Agilent 2100 Bioanalyzer and the
RNA 6000 LabChip kit (Agilent Technologies, Palo
Alto, CA, USA). To ensure good quality of further
analyses, only RNA of high purity and integrity were
included in the study. RNA purities (260:230 ratios)
were above 2, and RNA integrity numbers (RIN) were
between 9.4 and 10. Superscript III™ Indirect labelling
system (Invitrogen), Cy5 and Cy3 (Mono-Reactive Dye
Pack, Amersham Biosciences) were used to produce,
purify and fluorescence-label aminoallyl complementa-
ryDNA (cDNA)from15μgoftotal RNA, accordingto
the Invitrogen protocol for indirect labelling. A refer-
ence cDNA pool was made from 15 μg RNA from all
samples. Anchored primer (Oligo-dT) was used for
messenger RNA transcription. Reference (Cy3) and
sample (Cy5) labelled cDNAwere hybridised to micro-
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probes, representing close to 25,000 genes and
38,000 gene transcripts (mouse OpArray, 4.0,
Operon, Huntsville, AL, USA), according to the
manufacturers protocol. Images of hybridised slides
were captured using ScanArray® Express (Perkin
Elmer Inc., Waltham, MA, USA).
Bioinformatics and statistical analyses of microarray
data
After initial scanning of slides, background corrected
spot intensities were identified using the Bluefuse
software (BlueGnome Ltd., Cambridge, UK) and data
exported, including data on Bluefuse spot confidence
and probabilities of biological signal scores.
Expression-data was then imported into R using the
Bioconductor package Limma (Smyth et al. 2005).
Spots with <0.3 score from Bluefuse on probability of
biological signal for each channel in at least 70% of
arrays were filtered from further analysis. Colour
intensity plots for both channels (MA plots) and
between-array boxplots were used to visually assess
array quality. Arrays with severe hybridisation or
printing artefacts were removed. After quality filter-
ing, the remaining arrays for each condition included
casein control=5, fish control=4, fish low level=2,
casein high level=4, and fish high level=3. Each
sample represented one individual female pup on
PND18. No siblings were used for analysis or pooled
for hybridisation. These remaining 18 arrays with
22,476 quality assured spots were used for within-
array LOESS normalisation and between-array medi-
an scaling. Differentially expressed genes (all com-
pared to casein control) were identified for each
condition by a linear model with array weighting in
Limma (Smyth 2004; Ritchie et al. 2006). Due to the
small group size in the fish low group after quality
filtering, both low level groups were excluded from
further analyses. Benjamini–Hochberg multiple test-
ing correction was applied to unadjusted P values to
identify the false discovery rate (FDR) of each gene
(Benjamini and Hochberg 1995).
Functional clustering and selection of genes
for RT-qPCR validation
Lists of differentially expressed genes (in relation to
casein control) were imported into the Ingenuity
Pathway Analysis (IPA v 8.0, Ingenuity Systems
Inc.) to determine functional pathways affected by
the BDE47 exposure. Direct and indirect relationships
among genes from the Ingenuity Knowledge Base,
limited to mammalian “central nervous system cell
lines” and “the nervous system”, were used to explore
pathways and networks related to the regulated genes,
based on guidelines for Best Practice by IPA. Initial
filter criteria for genes to be included in networks
were log2 ratio of ±0.85 (∼1.8-fold change) and
FDR≤0.05. This filtering returned no genes eligible
for networks and pathways from the present study,
indicating limited cerebral gene-expression regulation
by BDE47. In order to produce a list of genes for
further examination in IPA, enabling selection of
genes of interest likely to be affected by BDE47, the
statistical stringency was relaxed. Genes were now
filtered based on log2 ratio as low as ±0.58 (fold
change, ∼1.5) and FDR=0.2. This produced a list of
52 network eligible genes and 273 genes eligible for
functions and pathways, at the cost of a lower
confidence. The genes that passed were from the
casein high level group only. No genes from the fish
high level or fish control groups passed this filtering,
indicating minimal regulation of genes in fish high
level and fish control groups. Genes from the fish
high level were finally filtered using a coarse filter of
FDR 0.4 in order to produce a gene list for inspection
and visualisation of results in IPA, with additional
loss of confidence in these genes.
The main criteria for genes to be selected for
validation by RT-qPCR were significant regulation
in this study and relevance to neuronal develop-
ment and function. Genes present in central net-
works and pathways in the IPA analyses were of
primary interest. Genes found in similar in vitro
a n di nv i v os t u d i e sp e r f o r m e db yt h e s eg r o u p s
(Carroll 2010) were considered of interest. The five
genes CXCR4, Rara, TRP53, Cyp1a1, Cyp2b10 and
Cyp3a11 were also chosen based on the biological
functions of their gene products in neurodevelop-
ment and toxicology. The chemokine receptor
CXCR4 h a sb e e nf o u n dt ob ei n v o l v e di nb r a i n
homeostasis and central nervous system (CNS)
development and plays an important role in neural
migration (reviews by Bajetto et al. 2001;R a n s o h o f f
et al. 2007). Retinoic acid receptor alpha (Rara)w a s
chosen based on the known role of retinoids in
morphogenesis, development and reproduction, as
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(review by Novak et al. 2008). TRP53 has been found
to have a central role in carcinogenesis and chromo-
some repair (Strachan and Read 1999; Verheyde et al.
2006). Cyp1a1, a well-known target gene in toxicology
and a toxicity biomarker for the Aryl hydrocarbon
receptor (AhR) (Hu et al. 2007), was included as a
negative control, as BDE47 has been shown to not
activate AhR in liver (Chen et al. 2001;B e h n i s c he ta l .
2003; Sanders et al. 2005;P e t e r se ta l .2006). Cyp2b10
and Cyp3a11 have been shown to be activated in liver
by non-coplanar PBDEs (Sanders et al. 2005;P a c y n i a k
et al. 2007) and were also included for RT-qPCR on
both liver and brain cDNA to elucidate the induction
of these genes in response to BDE47.
Two additional thyroid-responsive genes, nuclear
factor 1B (Nf1B) and insulin-like growth factor
binding protein (Igf2b), were found to be regulated
in both liver and brain after exposure to BDE47 in a
recent study (Suvorov et al. 2011) and were examined
by RT-qPCR for cross-study comparison. In addition
to thyroid responsiveness (Suvorov et al. 2011),
Igfbp2 is associated with regulation of cell growth
and signal transduction and has been shown to be
responsive to retinoic acid (Chambery et al. 1998),
while NfIB is also associated with DNA replication
and adenomas (Geurts et al. 1998).
RT-qPCR of selected genes
RNA for RT-qPCR was extracted from the same
snapfrozen brain tissue homogenate that was used for
microarray RNA extraction. Total RNA was extracted
from frozen homogenate in 1 ml Qiazol and DNase
treated using BioRobot EZ1 Workstation (Qiagen) as
specified by the manufacturer. For livers, the RNAs
from 18-day-old male and female pups were extracted
with Trizol as described for brain RNA. Liver RNA
was DNase treated using DNA-free
TM (Ambion).
Quality control was performed as described for
microarray RNA. RT-qPCR was performed as de-
scribed by Olsvik et al. (2009). A modification was
that the serial dilution standard curve was run in
duplicate from 31 to 125 ng to fit all samples into one
96-well plate. The reaction volume for the reverse
transcription reaction (RT-PCR) was 50 μl. The
resulting cDNA was diluted to 150 μl, and 2.5 μlo f
the diluted cDNA was transferred to a 384-well
reaction plate and the qPCR run in 10 μl reactions
on a LightCycler 480 Real-Time PCR System (Roche
Applied Sciences, Basel, Switzerland). The qPCR
was achieved with 10-min activation and denaturing
s t e pa t9 5 ° C ,f o l l o w e db y4 5c y c l e so fa1 5 - s
denaturing step at 95°C and a 60-s annealing and
elongation step at 60°C. A melt curve analysis was
performed for every gene. Reference genes for the
RT-qPCR were selected according to MIQE guide-
lines (Bustin et al. 2009). Three reference genes
(ATP5B, CANX and RPL13A) were selected from the
geNorm™ housekeeping gene selection kit (catalog
no. ge-Sy-6-mo, PrimerDesign Ltd, Southampton,
UK) by use of GeNorm (v3.5). Relative quantification
of genes was performed using the ΔΔ-Ct method,
based on a Ct value obtained from the second
derivative maximum of the curve. Two samples with
outlying values for several genes of interest, and with
large standard deviations among triplicates, were
removed. Final sample sizes for statistical analysis
of RT-qPCR data were the following: casein control=
6, fish control=5, casein high=4 and fish high=4.
Relative expression levels were compared using
Kruskal–Wallis test of independent samples, followed
by Mann–Whitney U pair wise comparisons (exact
test). Relative expression (evaluated by SYBR green
assays) was repeated in an independent laboratory. A
selection of genes was also tested using an additional
hydrolysis probe assay (TaqMan®).
Results
Comparability of diets
Analyses of the feeds verified that the levels of
protein, fat and vitamins were the same in fish- and
casein-based diets (Haave et al. 2011) and that the
metal concentrations were similar in all diets. For
most cases, the metal concentrations were close to or
below the LOQ (data not shown). Paired diets had
comparable BDE47 concentrations (Table 1). BDE47
was also the most prevalent congener in the control
feeds, although at very low concentrations. BDE99
was present at low levels in all diets, whereas all other
congeners analysed were only present in the fish-
based diets at low levels (Supplementary Table B),
underlining that despite the efforts to produce a clean
fish (Torstensen et al. 2008; Berntssen et al. 2010),
these substances are omnipresent in the environment
350 Cell Biol Toxicol (2011) 27:343–361and in food. However, concentrations of all other
contaminants than BDE47 in the final feeds were
considered sufficiently low to disregard any toxicity
arising from their presence.
Reproduction and physical development
No overt symptoms of toxicity or consistent differ-
ences in HSI in pups or dams were found throughout
the trial. After acclimation, there were no consistent
PBDE exposure-related group differences in body
weight among dams. No group differences were seen
in mean feed or PBDE intake, litter size or reproduc-
tive success among dams (Table 1). Dam feed intake
during lactation was significantly correlated with
number of pups born (Pearson’s product-moment
correlation r
2=0.84, p<0.001), but feed intake was
not influenced by a fish- or casein-based diet or the
concentration of BDE47. Pup body weight was
negatively correlated to litter size throughout lactation
(LME, p<0.001), but was not influenced by the
BDE47 exposure of the dam. Although litters were
reduced to five on PND5, the pup size remained
dependent on initial litter size (PND5) until PND18,
which meant that no compensatory growth or weight
gain was seen after culling on PND5. The nutritional
status of pups from all litters was considered good at
all times.
Pup tissue concentrations of BDE47 reflected
the maternal intake (Haave et al. 2011). The mean
concentration of BDE47 in brains on PND18 were
80±3 ng/g ww in the casein high group (n=6) and
62±9 ng/g ww in the fish high group (n=7). Casein
control and fish control both had PBDE47 concen-
trations in brain below 0.1 ng/g ww (n=2, two pools of
three samples analysed per group; Fig. 2). The level of
BDE47 in brains from the fish high group was similar
to casein high (p<0.1), although the levels of BDE47
in liver, fat and stomachs were consistently lower in
the groups fed the fish-based diets than that in the
casein-based diets (Haave et al. 2011).
Table 1 Feed concentration of BDE47, body weight, reproductive output, feed intake and ingested dose by reproducing dams fed
BDE47 in a fish- or a casein-based diet during gestation and lactation
Diet (n) BDE47
ng/g feed
Initial BW
dams (g)
Final BW
dams (g)
Repr. succ.
(%)
Litter size
(min–max)
Intake
gestation
(g/day)
Intake
lactation
(g/day)
Gestation dose
(μgk gB W
−1 day
−1
Lactation dose
(μgk gB W
−1 day
−1)
CC (7) 0.40±0.03 (3) 30.6±0.8 32.1±0.4 70 6.1 (1–10) 4.0±0.1 7.5±0.6 0.05±0.00 0.08±0.00
FC (6) 0.35±0.03 (3) 29.0±0.8 33.1±0.8 75 5.3 (2–9) 4.0±0.1 7.6±0.4 0.04±0.00 0.07±0.00
CL (3) 6.63±1.06 (3) 31.1±2.3 33.3±1.6 38 7.0 (4–11) 4.1±0.1 7.9±0.6 0.78±0.06 1.41±0.17
FL (5) 5.64±0.70 (3) 30.2±0.9 33.6±1.3 63 5.2 (1–8) 4.0±0.1 7.6±0.7 0.66±0.02 1.18±0.12
CH (6) 1900±74 (3) 30.0±1.0 31.8±0.7 75 7.0 (4–10) 4.0±0.0 7.8±0.3 227±8 421±22
FH (7) 1946±129 (3) 29.4±1.0 32.4±1.0 88 5.3 (3–9) 4.0±0.1 7.0±0.6 243±8 402±32
Data are presented as mean±SEM of analysed or calculated values. Sample size in brackets. Initial BW (bodyweight)=BW after
acclimation in females that produced live pups, final BW=BW at the end of weaning. Repr. succ.=successful reproduction in relation
to the number of mated females. Feed intake and dose during gestation (GD0–21) and lactation was based on daily monitoring of feed
intake. CC Casein control; FC fish control; CL casein low level; FL fish low level; CH casein high level; FH fish high level
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Fig. 2 Concentration of BDE47 in brains. Mean (±SEM)
concentration of BDE47 (ng/g wet weight) analysed in brains
from mouse pups on PND18. The pups were maternally
exposed to diets containing ∼0.4 μg BDE47/kg feed (control)
or ∼1,900 μg BDE47/kg feed (high level) throughout gestation
and lactation in a fish- or a casein-based feed. Casein Ctrl
(control) and Fish Ctrl, n=2; two pools of tissue with three
litters per pool; casein high level, n=6; fish high level, n=7
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The speed of development and the age of occurrence
of fully developed reflexes did not differ among
groups. The examination of the righting reflex and
hind limb grasp reflex showed significantly lower
reflex development in the fish high group after the
initial comparison of mean litter scores. As the
reflexes seemed affected by litter size, the statistical
analyses were repeated using GLM, correcting for
litter size. The GLM model supported the finding that
level of BDE47 exposure significantly affected right-
ing reflex on PND8 (p<0.05), also when correcting
for litter size. However, the post hoc assessment
showed that the righting reflex was only marginally
lower in BDE47 “high level” groups compared to
controls (p=0.055). In contrast, BDE47 exposure did
not affect hind limb grasp significantly, after the
correction for litter size using the GLM model. There
were no further differences in the early reflex
development scores, in physical development, grip
strength or hind limb splay in pups in relation to
BDE47 exposure. Detailed investigations failed to
discern any differences in spontaneous behaviour and
reactivity in the elevated plus maze.
Microarray analysis and qPCR validation
The gene list from casein high (filtered on log2 ratio
of ∼0.58 and FDR<0.2) was analysed in IPA and
used for selection of genes for qPCR validation
(Table 2). Genes from the fish high group were
filtered using a coarse filter of FDR 0.4 in order to
produce a gene list for import in IPA. Many of the
Table 2 Relative expression values for genes in the casein high level group compared to casein control
Entrez ID Gene name Microarray RT-qPCR
Log2 ratio FDR Log2 ratio Exact sign
(p value)
11423 Acetylcholinesterase (Ache) −0.75 0.13 −0.13 0.48
12064 Brain derived neurotrophic factor (Bdnf) 0.73 0.12 0.04 0.61
12767 Chemokine (C–X–C motif) receptor 4 (CXCR4)
a 0.38 0.36 −0.16 0.17
13385 Discs, large homolog 4 (Drosophila)( Dlgh4)
a −0.25 0.51 0.08 0.48
14810 Glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1) −0.99 0.09 0.09 0.76
14645 Glutamate-ammonia ligase (glutamine synthetase; Glul) 1.82 0.11 0.29 0.02
14828 Heat shock protein 5 (HSP5)
a 0.49 0.27 0.13 0.35
3485 Insulin-like growth factor binding protein 2 (Igfbp2)
a 0.43 0.2 0.63 0.04
67405 Neurotensin (Nts) 1.00 0.12 −0.05 0.76
4781 Nuclear factor I/B (Nf1B)
a −0.14 0.773 −0.27 0.17
18754 Protein kinase C, epsilon (Prkce) −1.56 0.09 0.17 0.17
19401 Retinoic acid receptor, alpha (Rara)
a −0.08 0.87 −0.52 0.04
105727 Solute carrier family 38, member 1 (Slc381) −0.59 0.12 −0.15 0.26
22059 Transformation related protein 53 (TRP53)
a 0.57 0.33 0.11 0.17
1543 Cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1)
a n.d. n.d. n.d. n.d.
1555 Cytochrome P450, family 2, subfamily 2, polypeptide 10 (Cyp2b10)
a n.d. n.d. n.d. n.d.
13112 Cytochrome P450, family 3, subfamily a, Polypeptide 11 (Cyp3a11)
a 0.3 0.5 n.d. n.d.
The genes were selected for validation by RT-qPCR. Genes were selected based on the statistical comparison of relative expression
values in casein high level versus casein control or based on biological function and presence in central IPA networks. Microarray data
represent log2 ratio compared to casein control. RT-qPCR data represent relative expression values transformed to log2 ratio for
comparison to microarray data. Significance values from statistical analyses of RT-qPCR data were obtained by Mann–Whitney U
comparison of relative expression values (exact test)
FDR False discovery rate; n.d. not detected, i.e. low expression values in microarrays and/or RT-qPCR
aSelected based on presence in central networks, or relevant biological functions and not from regulation according to the microarray
analysis
352 Cell Biol Toxicol (2011) 27:343–361same genes were recurring in top IPA networks and
pathways from both casein high level and fish high
level (Table 3). Moreover, the top functional network
from both casein and fish high level were termed
“cell-to-cell signalling and interaction, nervous sys-
tem development and function, and behaviour”
(Table 3). Additionally, “neurological disease” was
at the top of the IPA list of “related diseases and
disorders” for the casein high group (34 associated
genes, p<0.05). One of the main significant canonical
pathways in IPA was the glutamate signalling path-
way. The gene (Glul) for the converting enzyme
(Glutamate ammonia ligase) as well as synaptic
transporters of glutamate (Slc38-1) and downstream
receptors for glutamate in ion-channels (Grin1) were
regulated in the microarray analysis. However, RT-
qPCR confirmed only the regulation of Glul (Fig. 3a
and Table 2). The separate validation of a selection of
genes by TaqMan® probes gave no conflicting results.
Glul was among the separately validated genes.
Glutamate-ammonia ligase (Glul), which is central
to the glutamate signalling pathway, was one of the
most highly regulated genes in microarray analysis
(Table 2). Generally, the RT-qPCR results of selected
genes supported the original and more stringent
filtering of microarray data (log2 ratio of 0.85, FDR=
0.05), which had suggested no cerebral gene-
expression changes among groups. Among the five
genes that were chosen based on their relevant
biological function and previously shown relation to
Table 3 The top functional networks from microarray analysis of cerebral gene expression in murine offspring exposed to BDE47
during brain development
Upregulated,  
downregulated,   
added by IPA
IPA Score      # Focus 
  Molecules 
Cell-To-Cell 
Signalling and 
Interaction, Nervous 
System 
Development and 
Function, Behaviour
CDH2, CHN1 (includes EG:108699) ,
EPHA4, HTT, KLF4, S100A4
ACHE, APOE, APP, CDK5, 
CDK5R1, CTNNB1, DLG4, DPYSL2 , 
DRD1, FOS, GRIK2, GRIN1, 
GRIN2A, GSR, ITPR1, MAPK1, 
MAPK3, PEA15, RELA, SLC1A1, 
SLC1A2, SYN1, SYP, XBP1 
GRIN3A, IL6, IL1B, NOS1, NTF3
Nervous System 
Development and 
Function, 
Behaviour, 
Digestive System 
Development and 
Function 
BDNF, NTS 
AP2A2, APP, ARC, CACNG7, FOS , 
FYN, GAL, GRIA1, GRIA2, LEP, 
NR4A1, POMC, SNAP25, VAMP2 
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GABRG2
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Cell-To-Cell 
Signalling and 
Interaction, Nervous 
System 
Development and 
Function, Behaviour
DRD1, HTT, KLF4 
APP, CDK5, CTNNB1, CTTN, DLG4, 
GRIN1, GRIN2A, GRIN2B, MAPT,
PAK1, SLC1A2, SYP
none 
Top Functions Genes in network 
11 17 
69  
23  
55  
Red and green gene names in bold font means that the gene was regulated according to the filter criteria. A gene name in normal font
means that the gene was present in the list of regulated genes but did not pass the filter criteria: Log2 ratio of ±0.58 compared to
controls and FDR<0.2 (casein high level group) or FDR<0.4 (fish high level group). The functional analyses were generated through
the use of Ingenuity Pathways Analysis (Ingenuity® Systems, http://www.ingenuity.com)
Cell Biol Toxicol (2011) 27:343–361 353toxic responses, only Rara was shown by RT-qPCR to
be significantly downregulated in casein high level
compared to casein control (p<0.04, Fig. 3b). However,
the fold change for Rara was low (Table 2). Expression
data for Rara from microarray analysis did not pass
filtering in IPA (Table 2), indicating that the expression
change for Rara was minor and possibly at or below
the noise level for the microarray analysis in this study.
Cyp1a1, Cyp2b10 and Cyp3a11 were not significantly
regulated or even consistently expressed in the brains
according to both microarrays and RT-qPCR analyses.
The previous finding of two regulated thyroid
responsive genes (Igfbp2 and Nf1B) in liver and brain
(Suvorov et al. 2011) were tested by RT-qPCR and
were in part supported by the present study. Igfbp2
showed significant upregulation in brain in Casein
High level compared to casein control in qPCR
(Table 2, Fig. 3c). Also in the microarray analysis,
the gene was upregulated (log2 ratio, 0.43; FDR=
0.2), but did not pass the filtercriteria. There was no
regulation of Igfbp2 in fish high level. Nf1B was not
significantly regulated in the brain after BDE47
exposure (Table 2), but showed a slightly lower
expression in casein high than in casein control in
RT-qPCR. Also in microarrays, the gene for NfIB was
slightly downregulated (log2 ratio, −0.14), but did not
pass the filter in IPA.
To evaluate the general toxic response to BDE47
with the current exposure, the regulation of gene
expression for metabolic enzymes were analysed in
liver tissue of the pups. Although high concentrations
of BDE47 were detected in liver tissues, expression of
Cyp2b10 and Cyp3a11 did not change in BDE47
exposed groups compared to controls (data not
shown). Cyp1a1 was not significantly regulated
among groups, but showed trends to lower expression
in fish control compared to casein control. Cyp1a1
was highest expressed in casein control and was,
hence, not induced by BDE47 with the current
exposure (Fig. 4).
Similarly, the casein control group had the highest
mean expressions of Igfbp2and Nf1B in liver, but
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 Fig. 3 Relative expression of Glul, Rara and Igfbp2 in brains.
Relative expression levels in RT-qPCR of a glutamate ammonia
ligase (Glul), b retinoic acid receptor alpha (Rara) and insulin-
like growth factor binding protein 2 (Igfbp2) in female mouse
pup brains on PND18. Casein control, n=6; fish control, n=5;
casein high level, n=4; fish high level, n=4. Ctrl Control. *p<
0.05, significantly different from casein control (Mann–Whit-
ney U, exact significance test).
#p<0.1, trend from fish high
level (Mann–Whitney U, exact significance test)
354 Cell Biol Toxicol (2011) 27:343–361there were no significant differences among groups
(Kruskal–Wallis, exact test, p>0.6 for each gene).
Discussion
Tissue levels and exposure regime
The study investigated the neurotoxicity of BDE47
exposure to mice at the most vulnerable period of
brain development, using an exposure pathway
relevant to humans. Two experimental levels were
tested and represented a realistic and an extreme
scenario. However, it needs to be considered that the
toxicokinetics of BDE47 in mice are different from
humans, and direct extrapolation to human effects is
thus not warranted. Mice are widely used as models in
studies of neurotoxicity and in neurological research
(Tilson 1991; Bignami et al. 1992; Eriksson 1996;
Branchi et al. 2002; Darnerud 2003; Viberg 2004;
Eriksson et al. 2006). However, mice have a much
more rapid excretion of BDE47 than humans (Orn
and Klasson-Wehler 1998; Staskal et al. 2005), and
the risks to humans may therefore be underestimated
using mice as a model organism.
Accumulation in pup brains (up to ∼80 ng/g ww)
reflected maternal dietary intake. The results of the
present study suggest that the current BDE47 expo-
sure did not notably affect physical or neurobeha-
vioural development in mice. Only one gene was
found to be consistently regulated by both microarray
and RT-qPCR in the casein high level group, and
additionally two genes were found to be regulated by
RT-qPCR. However, most genes were not affected by
the gestational and lactational BDE47 exposure in
either casein or fish groups. Hepatic metabolic
enzymes and thyroid responsive genes in pups were
similarly not induced by the high exposure to BDE47,
although studies have indicated that a limited hepatic
metabolism is present at the age of weaning in mice
(Staskal et al. 2005).
The feed contaminant load was largely restricted to
BDE47, and the concentrations of other contaminants
were very low. Using a virtually clean control feed
with negligible levels of other environmental con-
taminants was advantageous to delineate the results to
effects of BDE47 alone and diminished the problem
of additive, synergistic or antagonistic effects, which
might have precluded the interpretation. This was
achieved using fish samples raised on low contami-
nant diets. BDE47 is the most prevalent PBDE
congener in human samples, comprising over 50%
of the PBDEs in breast milk (Meironyte et al. 1999;
Noren and Meironyte 2000), and identification of
effects of exposure to this congener is thus valuable.
The exposure to metabolites of BDE47, which is
achieved via lactational transfer, is highly realistic
when attempting to mimic maternal exposure in
breastfed infants.
Previous studies that have found PBDE-induced
cognitive impairment and altered activity have often
used a single oral dose of 1.4 μmol/kg BW (Eriksson
et al. 2001), which is higher than the average daily
dose to dams used in this study and similar to the
peak dose during lactation. Estimations based on
previous publications (Darnerud and Risberg 2006)
suggested that pups would receive a daily dose per
kilogram BW that would be higher than the single
oral dose previously administered on PND10. The
analyses of brain tissue in this study showed that the
concentrations of BDE47 in brains on PND18 were
high and similar to those reported previously, where
1 mg BDE47/kg BW had been given orally to mice
pups on PND22 (Staskal et al. 2006). The oral dose
given on PND22 (Staskal et al. 2006) was comparable
to the dose shown to induce behavioural effects after
neonate oral exposure to a single dose on PND10 in
mice (Eriksson et al. 2001). This shows that the
maternal exposure mode used for this study represents
an efficient transfer of BDE47 to pups and that the
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Fig. 4 Relative expression of Cyp1a1 in liver. Relative
expression levels in RT-qPCR for Cyp1a1 in livers of
maternally exposed offspring on PND18. Bars and error bars
signify mean±SEM. Ctrl Control
Cell Biol Toxicol (2011) 27:343–361 355accumulated dose received by the pups was compa-
rable to the single oral dose used in studies that have
previously shown behavioural effects after pup
exposure (Eriksson et al. 2001, 2002, 2006; Viberg
et al. 2003a,b, 2004; Suvorov et al. 2009). However,
using maternal exposure to mimic human exposure
complicates direct comparison to previous studies
where behavioural effects have been demonstrated
after direct oral dosing to pups. The present study
may also suggest that a single, high bolus dose during
brain growth may be more toxic than a continuous
chronic exposure, even if comparable levels are
present in the brains at the vulnerable time of BGS.
However, an acute and high exposure is rarely
experienced in humans, and exposure via the mother
may better mimic chronic human exposure.
Toxic effects of continuous BDE47 exposure
The finding that the continuous maternal exposure to
BDE47 during gestation and lactation has little effect
on growth, weight gain or physical and early neuro-
behavioural development in the offspring supports
previous findings (Gee and Moser 2008). The present
study suggested a possible low-grade effect on early
reflex development, but no effects of exposure could
be detected on PND18, indicating that any early
reflex impairment was transient. Previous studies
have documented the validity and efficiency of the
neurobehavioural tests used and have previously
detected neurobehavioural differences in mouse pups
exposed to seafood toxicants (Folven et al. 2009;
Glover et al. 2009). It seems to be a recurring finding
that PBDEs do not overtly affect physical develop-
ment or reflex development and motor coordination
(Branchi et al. 2002; Gee and Moser 2008; Suvorov et
al. 2009). However, complex behaviour, such as
habituation, learning and spontaneous activity, have
consistently been affected by several PBDEs includ-
ing BDE47 (Viberg et al. 2003a,b, 2004, 2006). This
effect of PBDEs on the complex cognitive functions
also gain support from recent human epidemiological
studies (Herbstman et al. 2010). The lack of effects in
spontaneous behaviour and reactivity in the elevated
plus maze may be due to the immature behaviour of
the pre-weanling pups, which made spontaneous
testing difficult. In order to differentiate between
groups, a certain range of behaviour must be
displayed. The spontaneous and exploratory behav-
iour of the pups in the elevated plus maze was
different from adult-like behaviour in that they did not
actively explore the arena (Cuomo et al. 1996). The
pre-weanling pups showed similar limited behaviour
as described by Glover et al. (2009) at PND15.
Extending the time spent in the elevated plus maze
was not feasible at this age. It was considered unlikely
that such an extension would have altered pup
behaviour to a great extent.
Concerning the age of testing, previous studies
indicate that behavioural responses to perinatal PBDE
exposure during development manifests in adulthood
(Eriksson et al. 2001; Viberg et al. 2003b), and it is
possible that an overt behavioural response had not
developed at the time of testing. Such “silent
neurotoxicity” has previously been reported for both
drugs and toxicants (Reuhl 1991; review by Costa et
al. 2004).
The toxicogenomic approach aimed at detecting
the early changes that were believed to precede
behavioural changes in adulthood and thus help
delineate the mechanisms of BDE47 toxicity. Sensi-
tive molecular methods indicated significant gene-
expression regulation of three of the investigated
genes (Glul, Rara and Igfbp2) at the investigated time
point. Glul was the most highly regulated gene in this
study (Table 2). Finding a total of three regulated
genes among 37,000 genes on the microarray slide
does not point to an immense impact of the current
exposure on gene expression regulation. On the other
hand, the finding of regulation of Glul is further
supported by the glutamate signalling pathway in IPA
being significantly associated with several other
regulated genes from the present study.
Regulation of Glul may have consequences for the
CNS. Upregulation of Glul could be interpreted as a
compensation for a disturbance in glutamine synthesis
or neurotransmission. Glul takes part in the removal
of glutamate, which is one of the major neuro-
transmitters in the brain. Moreover, glutamate is
among the excitatory amino acids (EAA) that have
great potential for involvement in neurodegenerative
disease (Olney 1990) and may be a mechanistic link
to the development of attention deficit hyperactive
disorder. Disruptions of the EAA balance during
development, both in the form of too high or too
low levels, may lead to neurological disorders (Olney
1990). Glutamate is also a ligand for the N-methyl-D-
aspartate (NMDA) receptor (Grin1, Table 2), which
356 Cell Biol Toxicol (2011) 27:343–361was regulated according to microarray analyses.
NMDA also plays a large role in the mechanisms of
excitotoxicity (Olney 1990). However, in the qPCR
validation, the gene for the NMDA receptor was
found not to be significantly regulated. Nevertheless,
the effects of disruption and a time of vulnerability to
EAAs postulated by Olney (1990) are highly inter-
esting in light of the later behavioural changes
observed by Eriksson (1997)a n dV i b e r ge ta l .
(2003b). The present study thus lends some support
to these previous studies, which may be of interest for
future investigations.
The present study also supported the previously
published up regulation of Igfb2 in the brain after
BDE47 exposure (Suvorov et al. 2011) but did not
observe the same regulation of Igfb2 in the liver.
The third regulated gene described in the current
analysis, Rara, has previously been used as a
biomarker for environmental pollutants (review by
Novak et al. 2008) and was also indicated as a gene of
interest by these groups after exposure of mice to
BDE47 (data not published). Another gene, Prkce,
was indicated as downregulated in microarrays for
this and a previous study (Suvorov et al. 2011), but
not validated by RT-qPCR in either study. Moreover,
the enzyme protein kinase C has been found to be
affected by PBDEs in previous in vitro studies
(Kodavanti and Ward 2005). Although not validated
in the present study, these findings suggest that the
four mentioned genes may be of interest for future
research concerning mechanisms for PBDE toxicity.
Most genes in the present study showed no
significant regulation in RT-qPCR. This corresponded
well to the original IPA filtering of microarray results,
where no genes passed the filter as significantly
regulated. The microarray analyses and RT-qPCR
validations also indicated that changes were small
when present. This indicates that BDE47 exposure
does not induce cerebral gene-expression changes at
this age and under the current mode of exposure.
Based on this study and previous publications, the
gene expression in the brain seems remarkably stable
and expression changes in response to non-biotic
stimuli seem generally low. Previous studies have
reported relatively low fold changes in cerebral gene-
expression after exposure to mixtures of PCBs,
methyl mercury and organochlorines (Padhi et al.
2008; Royland and Kodavanti 2008; Royland et al.
2008; Glover et al. 2009). The marginal regulation of
gene expression in the present study may also reflect
the relatively low concentrations of PBDEs found in
brains compared to other tissues, such as the liver.
In support of the seemingly low toxicity in the
present study, none of the examined genes for hepatic
metabolic enzymes were regulated by exposure to
BDE47, although xenobiotic metabolic capacity has
been demonstrated at the age of weaning (Staskal et
al. 2006). This suggests that the hepatic toxicity of
BDE47 is limited or that commonly used markers of
toxicity are not induced by BDE47. Similarly, the
present study did not support the previously published
regulation of Igfb2 or Nf1B in the liver after BDE47
exposure (Suvorov et al. 2011). However, differences
between studies may be caused by inter-species
differences and the different modes of exposure used.
The result of the study does not exclude that possible
effects of PBDE exposure may be measurable in pups
by other methods or at different time points. For
example, the age of sampling for microarray analysis
is of importance, as previously demonstrated (Royland
and Kodavanti 2008), and the present study may have
missed the peak of gene-expression regulation. Com-
pensatory mechanisms induced by the long-term
exposure may also have reduced the responses, or the
responses may be delayed, suggesting that time of
sampling might be a key facet in determining changes
in cerebral gene expression.
Conclusion
BDE47 accumulated in the brain of maternally exposed
mice, reflecting the maternal intake. The accumulated
levels of BDE47 in the brain did not exert measurable
effects on physical development or reflexes in 18-day-
old pups. Changes related to BDE47 exposure and diets
were found by microarray and RT-qPCR analysis of
global cerebral gene expression in mouse pups and may
suggest effects in the area of neurodevelopment and
cell-to-cell signalling via disturbance of the glutamate
signalling system and genes involved in signal trans-
duction, growth and maturation of the CNS. The effects
that were observed by a toxicogenomic approach
occurred in the high level group where dams were fed
BDE47 in a casein-based diet. No significant effects
were detected in the group where dams were fed high
levels of BDE47 in a fish-based diet, which indicates a
potential ameliorating effect of nutrients on PBDE-
Cell Biol Toxicol (2011) 27:343–361 357induced gene expression changes. The present study
indicates that toxic effects of BDE47 on the brain and
liver may not be manifested as detectable gene
regulation, even after a continuous high exposure to
the congener during a vulnerable phase of foetal and
neonatal development. This does not exclude that
changes may be present and detectable by methods that
were not investigated in this study. Targeted investiga-
tion of pathways and gene products outlined in the
present study may further elucidate the mechanisms of
effect of PBDEs, which have lead to the previously
observed behavioural changes in mice offspring after
perinatal PBDE exposure.
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